Korean J Hematol 1999; 34(1):
Published online March 31, 1999
© The Korean Society of Hematology
송영두, 이경희, 현명수
영남대학교 의과대학 내과학교실
Background: Idiopathic thrombocytopenic purpura(ITP) is an autoimmune disorder characterized by a severe reduction in the number of circulating platelets. Corticosteroid therapy, which has been used in ITP for many years, has produced a complete or partial response rate of 65% to 75%, although sustained remissions have been reported in only 18% to 32%, of the patients. The purpose of the present study is to define response to each treatment and ultimate outcome of adults with ITP.
Method : A clinical study was done on 35 casas of ITP who had admitted to the department of Internal Medicine, Yeungnam University Hospital from June 1983 to July
1996. Ths response of each treatment modalities was basso on criteria of Defino and Cooperative Latin American Group on Hsmostasis and Thrombosis.
Results: The mean ass of patients was 41.9 years old and female to male ratio was 1:0.6 (female:22 casas, mals:13 cases). The complete response rate to intravenous γ
-globulin as early therapy was obtained in 72% of the patients and the duration to platelet count above 50,000/μL was 3 days after intravenous γ-globulin therapy.
Duration of response was 15 days. Ths CCR(continuing complete response) to cortlcosterold was obtained in 16% of the patients, and no CCR to reinduction with corticosteroid was observed. Ths CR to splenectomy was obtained in 85% of the patients. The overall results of all therapeutic modalities were CCR 43%, TCR(temporary complete response) 20%, PR(partial response) 31%, and NR(no response) 6%.
Conclusion: This analysis of ITP in adults suggests that splenectomy remains as the most effective treatment and intravenous γ-globulin is effective for rapid elevation of
platelet count.
Keywords Idiopathic Thrombocytopsnic Purpura, Therapy, Ⅳ γ-globulin, Splenectomy, Steroid
Korean J Hematol 1999; 34(1): 62-70
Published online March 31, 1999
Copyright © The Korean Society of Hematology.
송영두, 이경희, 현명수
영남대학교 의과대학 내과학교실
Young Doo Song, Kyung Hee Lee, Myeung Soo Hyun
Department of Internal Medicine, College of Medicine, Yeungnam University, Taegu, Korea
Background: Idiopathic thrombocytopenic purpura(ITP) is an autoimmune disorder characterized by a severe reduction in the number of circulating platelets. Corticosteroid therapy, which has been used in ITP for many years, has produced a complete or partial response rate of 65% to 75%, although sustained remissions have been reported in only 18% to 32%, of the patients. The purpose of the present study is to define response to each treatment and ultimate outcome of adults with ITP.
Method : A clinical study was done on 35 casas of ITP who had admitted to the department of Internal Medicine, Yeungnam University Hospital from June 1983 to July
1996. Ths response of each treatment modalities was basso on criteria of Defino and Cooperative Latin American Group on Hsmostasis and Thrombosis.
Results: The mean ass of patients was 41.9 years old and female to male ratio was 1:0.6 (female:22 casas, mals:13 cases). The complete response rate to intravenous γ
-globulin as early therapy was obtained in 72% of the patients and the duration to platelet count above 50,000/μL was 3 days after intravenous γ-globulin therapy.
Duration of response was 15 days. Ths CCR(continuing complete response) to cortlcosterold was obtained in 16% of the patients, and no CCR to reinduction with corticosteroid was observed. Ths CR to splenectomy was obtained in 85% of the patients. The overall results of all therapeutic modalities were CCR 43%, TCR(temporary complete response) 20%, PR(partial response) 31%, and NR(no response) 6%.
Conclusion: This analysis of ITP in adults suggests that splenectomy remains as the most effective treatment and intravenous γ-globulin is effective for rapid elevation of
platelet count.
Keywords: Idiopathic Thrombocytopsnic Purpura, Therapy, Ⅳ γ-globulin, Splenectomy, Steroid
Seug Yun Yoon, Jong-Ho Won
Blood Res 2021; 56(S1): S44-S50José Carlos Jaime-Pérez, Patrizia Aguilar-Calderón, Lorena Salazar-Cavazos, Andrés Gómez-De León, David Gómez-Almaguer
Blood Res 2019; 54(2): 131-136Jae Joon Han, Sun Kyung Baek, Jae Jin Lee, Si-Young Kim, Kyung Sam Cho, and Hwi-Joong Yoon
Korean J Hematol 2010; 45(3): 197-204